Associate Director Technical CMC Operations

US FDA Gives Positive Feedback on PharmaEssentia's Cancer Drug Trial Request

Taiwania Capital Management Corporation Portfolio - PharmaEssentia

PharmaEssentia to Participate at Morgan Stanley 23rd Annual Global Healthcare Conference

Myeloproliferative Disorder Treatment Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Novartis, Incyte, Bristol Myers Squibb, CTI BioPharma, GSK, PharmaEssentia

Associate Director, Government Pricing and Reporting

PharmaEssentia USA Corporation is a rapidly growing biopharmaceutical innovator focused on delivering effective new biologics for challenging diseases in hematology and oncology. The Associate Director, Government Pricing and Reporting will oversee pricing strategies and compliance reporting related to government healthcare programs, ensuring accurate pricing models and regulatory compliance while building strong partnerships with stakeholders.

Sign up with Google

Sign in with Google